CircPDSS1 (hsa_circ_0017998) silencing induces ferroptosis in non-small-cell lung cancer cells by modulating the miR-137/SLC7A11/ GPX4/GCLC axis

被引:1
|
作者
Wu, Ling [1 ,2 ]
Li, Ni [1 ]
Zhu, Linwen [1 ]
Shao, Guofeng [1 ]
机构
[1] Ningbo Univ, Lihuili Hosp, Dept Cardiovasc Surg, Ningbo 315000, Zhejiang, Peoples R China
[2] Ningbo Univ, Women & Childrens Hosp, Ningbo 315000, Zhejiang, Peoples R China
关键词
circPDSS1; Ferroptosis; GPX4; GCLC; miR-137; Non-small cell lung cancer; CISPLATIN RESISTANCE; CIRCULAR RNAS; PROGRESSION; EXPRESSION;
D O I
10.1016/j.tiv.2024.105887
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Background: Circular RNAs (circRNAs) regulate the tumorigenesis of non-small-cell lung cancer (NSCLC). CircPDSS1 (hsa_circ_0017998) has been newly discovered, and its role in NSCLC remains elusive. We aimed to investigate the functional roles and downstream targets of circPDSS1 in NSCLC cells. Materials and methods: Cellular viabilities were measured through the Cell Counting Kit-8 (CCK-8) assay, whereas cell death was assessed through flow cytometry. The lactate dehydrogenase activity, malondialdehyde levels, ferrous iron, and reactive oxygen species were measured using commercial assay kits. The interaction between circPDSSA/ microRNA-137 (miR-137) and miR-137/solute carrier family 7 member 11 (SLC7A11) was assayed through a dual luciferase activity assay. Finally, the mRNA and protein levels were measured using real-time reverse transcriptase-polymerase chain reaction and western blots, respectively. Results: CircPDSS1 expression was upregulated in NSCLC cells, compared with healthy lung cells. CircPDSS1 silencing suppressed the viability of NSCLC cells. Additionally, circPDSS1 knockdown induced ferroptosis rather than other types of cell death in NSCLC cells. Mechanically, circPDSS1 functions as a " sponge " to inversely control miR-137 expression, which directly targets SLC7A11. Moreover, circPDSS1 silencing causes the downregulation of glutathione peroxidase 4 (GPX4) and glutamate-cysteine ligase catalytic subunit (GCLC). Conclusions: Targeting the circPDSS1/miR-137/SLC7A11/GPX4/GCLC axis may be a promising strategy to kill NSCLC cells.
引用
收藏
页数:11
相关论文
共 7 条
  • [1] Lanatoside C induces ferroptosis in non-small cell lung cancer in vivo and in vitro by regulating SLC7A11/GPX4 signaling pathway
    Xia, Yaozong
    Liu, Teng
    Deng, Shihua
    Li, Jin
    Zhang, Feng
    He, Shuang
    Yuan, Wei
    Wu, Dongming
    Xu, Ying
    TRANSLATIONAL CANCER RESEARCH, 2024, 13 (05) : 2295 - 2307
  • [2] 3,3′-diindolylmethane induces ferroptosis and inhibits proliferation in non-small-cell lung cancer through the AHR/NRF2/GPX4 axis
    Lin Guo
    Jia Zhang
    Yuqiang Li
    Yuehong Gao
    Jiali Huang
    Mengru Liu
    Jing Li
    Wenshu Chai
    Yubin Li
    Discover Oncology, 16 (1)
  • [3] Trabectedin induces ferroptosis via regulation of HIF-1?/IRP1/TFR1 and Keap1/Nrf2/GPX4 axis in non-small cell lung cancer cells
    Cai, Shunv
    Ding, Zewu
    Liu, Xinyi
    Zeng, Jian
    CHEMICO-BIOLOGICAL INTERACTIONS, 2023, 369
  • [4] Retraction Note: LncRNA PCGEM1 induces proliferation and migration in non-small cell lung cancer cells through modulating the miR-590-3p/SOX11 axis
    Huanshun Wen
    Hongxiang Feng
    Qianli Ma
    Chaoyang Liang
    BMC Pulmonary Medicine, 22
  • [5] RETRACTED ARTICLE: LncRNA PCGEM1 induces proliferation and migration in non-small cell lung cancer cells through modulating the miR-590-3p/SOX11 axis
    Huanshun Wen
    Hongxiang Feng
    Qianli Ma
    Chaoyang Liang
    BMC Pulmonary Medicine, 21
  • [6] RETRACTED: LncRNA PCGEM1 induces proliferation and migration in non-small cell lung cancer cells through modulating the miR-590-3p/SOX11 axis (Retracted Article)
    Wen, Huanshun
    Feng, Hongxiang
    Ma, Qianli
    Liang, Chaoyang
    BMC PULMONARY MEDICINE, 2021, 21 (01)
  • [7] RETRACTION: LncRNA PCGEM1 induces proliferation and migration in non-small cell lung cancer cells through modulating the miR-590-3p/SOX11 axis (Retraction of Vol 21, art no 234, 2021)
    Wen, Huanshun
    Feng, Hongxiang
    Ma, Qianli
    Liang, Chaoyang
    BMC PULMONARY MEDICINE, 2022, 22 (01)